Kidney transplant medication: promising monthly infusion trial in 2026

Kidney transplant patient receiving a monthly infusion in NHS hospital, kidney transplant medication

A new UCSF phase 2 trial offers early hope that kidney transplant medication could one day shift from a daily cocktail of tablets to a monthly infusion, with the potential to reduce side effects and protect the donor kidney for longer. We explain what the researchers found and what it could mean for kidney transplant patients in the UK.